Skip to content

Clinical trials

Phase 1/2 Neuroblastoma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1/2 Country / region: Israel Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20141
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Completed1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization2
Genzyme, a Sanofi Company1
Merck Sharp & Dohme LLC1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma5
Neoplasm Metastasis2
Sarcoma2
Brain Neoplasms1
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1
Glioblastoma1
Lymphoma, Large B-Cell, Diffuse1
Melanoma1
Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.